Results 71 to 80 of about 2,363,412 (175)

Aspirin resistance Aspirin Direnci

open access: yes, 2004
Aspirin is an effective antithrombotic agent for many patients. However, patients taking aspirin might exhibit variable responses to in vitro tests for platelet aggregation and might experience breakthrough thromboembolic events. Although this phenomenon
YILMAZ, MEHMET BİRHAN   +2 more
core  

Aspirin Resistance

open access: yes, 2017
Aspirin is a non-steroidal anti-inflammatory drug. It is used for the prevention of thrombo-embolism in patients at risk for getting them.Aspirin resistance is a term coined from people who take aspirin and still get thrombo-embolism.
Ehinmisan, Ayara Onome
core  

Aspirin resistance status as determined by urinary thromboxane B2 (TXB2) level in patients with ischemic heart disease and its relationship with Severity of coronary artery disease

open access: yesمجله دانشکده پزشکی اصفهان, 2011
Background: Coronary artery disease (CAD) and myocardial infarction are the most common cause of mortality and morbidity all over the world..
Naghmeh Ziaie   +5 more
doaj  

Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line

open access: yesMediators of Inflammation, 2015
Overexpression of efflux transporters, in human cells, is a mechanism of resistance to drug and also to chemotherapy. We found that multidrug resistance protein-4 (MRP4) overexpression has a role in reducing aspirin action in patients after bypass ...
Isabella Massimi   +6 more
doaj   +1 more source

Aspirin Resistance in Patients Undergoing Hemodialysis and Effect of Hemodialysis on Aspirin Resistance

open access: yesClinical and Applied Thrombosis/Hemostasis, 2013
The aim of this study was to evaluate the prevalence of aspirin resistance (AR) in patients undergoing hemodialysis (HD) and to assess the effect of HD on the results of the Multiplate test. A total of 54 patients undergoing HD were included in this study. Blood samples were taken just before and after the HD session.
Hale Unal, Aksu   +9 more
openaire   +2 more sources

Thienopyridine Resistance Among Patients Undergoing Intracoronary Stent Implantation and Treated With Dual Antiplatelet Therapy: Assessment of Some Modifying Factors

open access: yesJournal of Pharmacological Sciences, 2008
In this open, prospective study we assessed the prevalence of antiplatelet resistance among patients subjected to intracoronary stent implantation. In patients treated with aspirin + thienopyridine (N = 32), platelet reactivity index (PRI) significantly ...
Nina Djukanovic   +5 more
doaj   +1 more source

Aspirin: promise and resistance in the new millennium.

open access: yes, 2008
Although conceived at the end of the 19th century, aspirin remains the gold standard of antiplatelet therapy. Approximately 100 randomized clinical trials have established its efficacy and safety in the prevention of myocardial infarction, ischemic ...
Patrono, Carlo, Rocca, Bianca
core  

Aspirin resistance in systemic lupus erythematosus. A pilot study

open access: yes, 2013
Systemic lupus erythematosus (SLE) patients are at increased risk of thrombosis and cardiovascular diseases. Aspirin is an effective treatment option for these patients.
Ertenli, I.   +8 more
core   +1 more source

Does high serum uric acid level cause aspirin resistance?

open access: yes, 2016
In patients with coronary artery disease (CAD), though aspirin inhibits platelet activation and reduces atherothrombotic complications, it does not always sufficiently inhibit platelet function, thereby causing a clinical situation known as aspirin ...
Kılıç, İsmail Doğu   +6 more
core   +1 more source

ACETYLSALICYLIC ACID RESISTANCE: RISK FACTORS, MECHANISMS, DIAGNOSTIC TESTS

open access: yesJuvenis Scientia, 2020
Acetylsalicylic acid (aspirin) is one the most widespread drugs in the world. It is used for secondary prevention of atherothrombotic events in patients with cardiovascular disease.
K.Yu. Lukianets, I.Yu. Pchelin
doaj  

Home - About - Disclaimer - Privacy